COPD Exacerbation Follow Up
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
- Status
- RECRUITING
- Phase
- PHASE3
Incidence of Retinal Vasculitis Among Patients Receiving Aflibercept: A US Real-World Evidence Study
- Status
- COMPLETED
- Phase
- N/A
Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treated With Cemiplimab.
- Status
- RECRUITING
- Phase
- N/A
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Status
- RECRUITING
- Phase
- PHASE4
Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions
- Status
- RECRUITING
- Phase
- N/A
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
- Status
- RECRUITING
- Phase
- PHASE3
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation Study With Bispecific Antibodies in Adult Patients With Lupus Nephritis
- Status
- RECRUITING
- Phase
- PHASE1
Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy
- Status
- RECRUITING
- Phase
- PHASE3
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to Deepen Responses or Redrive MRD Negativity After Relapse
- Status
- RECRUITING
- Phase
- PHASE2
XL092 and Cemiplimab in BRAF WT Thyroid Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2